Accounting for anovulation and vaginal thinning during depot medroxyprogesterone acetate use
Atrio, J.
Journal of Infectious Diseases 211(5): 850
2015
ISSN/ISBN: 1537-6613 PMID: 25217405 DOI: 10.1093/infdis/jiu518Document Number: 626446
Document emailed within 0-6 h
Related Documents
Zia, Y.; Tang, J.H.; Chinula, L.; Tegha, G.; Stanczyk, F.Z.; Kourtis, A.P. 2019: Medroxyprogesterone acetate concentrations among HIV-infected depot-medroxyprogesterone acetate users receiving antiretroviral therapy in Lilongwe, Malawi Contraception 100(5): 402-405Yang, L.; Hao, Y.; Hu, J.; Kelly, D.; Li, H.; Brown, S.; Tasker, C.; Roche, N.E.; Chang, T.L.; Pei, Z. 2019: Differential effects of depot medroxyprogesterone acetate administration on vaginal microbiome in Hispanic White and Black women Emerging Microbes and Infections 8(1): 197-210
Chandra, N.; Thurman, A.R.; Anderson, S.; Cunningham, T.D.; Yousefieh, N.; Mauck, C.; Doncel, G.F. 2013: Depot medroxyprogesterone acetate increases immune cell numbers and activation markers in human vaginal mucosal tissues Aids Research and Human Retroviruses 29(3): 592-601
Sturm, G.; Antal, E.; Schmidt Rhode, P.; Bauer, T.; Schulz K D. 1986: Medroxyprogesterone acetate and immunoreactive medroxyprogesterone acetate metabolites measured by two different selective radioimmunoassay antibodies in medroxyprogesterone acetate treated breast cancer patients Anticancer Research 6(3 Part A): 362
Cromwell, P.; Anyan, W. 1998: Depot medroxyprogesterone acetate galactorrhea Journal of Adolescent Health: Official Publication of the Society for Adolescent Medicine 23(2): 61
Bonhomme, M.G.; Potts, D.M.; Fortney, J.A.; Allen, M.Y. 1991: Safety of depot medroxyprogesterone acetate Lancet 338(8772): 942
Bakry, S.; Merhi, Z.O.; Scalise, T.J.; Mahmoud, M.S.; Fadiel, A.; Naftolin, F. 2008: Depot-medroxyprogesterone acetate: an update Archives of Gynecology and Obstetrics 278(1): 1-12
Mishell, D.R. 1996: Pharmacokinetics of depot medroxyprogesterone acetate contraception Journal of Reproductive Medicine 41(5 Suppl): 381-390
Cullins, V.E. 1996: Noncontraceptive benefits and therapeutic uses of depot medroxyprogesterone acetate Journal of Reproductive Medicine 41(5 Suppl): 428-433
Kaunitz, A.M.; Grimes, D.A. 2011: Removing the black box warning for depot medroxyprogesterone acetate Contraception 84(3): 212-213
Sathyamala, C.; Shah, P.; Jain, Y.; Bhargava, A. 1994: Use of injectable depot medroxyprogesterone acetate in lactating Indian women Lancet 344(8915): 134-135
Arowojolu, A.O. 2000: Treatment of endometriosis with depot medroxyprogesterone acetate: a preliminary experience African Journal of Medicine and Medical Sciences 29(1): 55-58
Kaunitz, A.M. 1994: Long-acting injectable contraception with depot medroxyprogesterone acetate American Journal of Obstetrics and Gynecology 170(5 Pt 2): 1543-1549
Frederiksen, M.C. 1996: Depot medroxyprogesterone acetate contraception in women with medical problems Journal of Reproductive Medicine 41(5 Suppl): 414-418
Guirguis-Blake, J. 2011: Copper intrauterine device vs. depot medroxyprogesterone acetate for contraception American Family Physician 83(1): 35-36
Lumbiganon, P. 1994: Depot-medroxyprogesterone acetate (DMPA) and cancer of the endometrium and ovary Contraception 49(3): 203-209
Bloch, B. 1971: Depot medroxyprogesterone acetate (Depo-Provera) as a contraceptive preparation South African Medical Journal 45(28): 777-780
Sathyamala, C.; Shah, P.; Jain, Y.; Bhargava, A. 1994: Use of injectable depot medroxyprogesterone acetate in lactating Indian women Lancet 344(8915): 134-135
Lumbiganon, P. 1994: Depot-medroxyprogesterone acetate (DMPA) and cancer of the endometrium and ovary Contraception 49(3): 203-209
Torok, M.R.; Miller, W.C.; Hobbs, M.M.; Macdonald, P.D.M.; Leone, P.A.; Schwebke, J.R.; Seña, A.C. 2009: The association between oral contraceptives, depot-medroxyprogesterone acetate, and trichomoniasis Sexually Transmitted Diseases 36(6): 336-340